MedTrace Logo

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

NCT05438836 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2023-09-25

No results posted yet for this study

Summary

A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).

Conditions

  • Anal Cancer
  • Anal Carcinoma
  • Anal Squamous Cell Carcinoma

Interventions

RADIATION

online adaptive radiotherapy

Online adaptive radiotherapy compared to standard non-adaptive Image-Guided Radiotherapy

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Eva S Serup-Hansen, MD, PhD · Herlev og Gentofte Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2026-01-01
Completion
2031-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438836 on ClinicalTrials.gov